Detalles de la búsqueda
1.
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study.
Blood
; 137(13): 1792-1803, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33024987
2.
Pharmacokinetic/Pharmacodynamic Evaluation of Ivosidenib or Enasidenib Combined With Intensive Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed IDH1/2-Mutant Acute Myeloid Leukemia.
Clin Pharmacol Drug Dev
; 11(4): 429-441, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35166065
3.
Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Oral Ivosidenib in Otherwise Healthy Participants.
Clin Pharmacol Drug Dev
; 10(1): 99-109, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32648303
4.
A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML.
Blood Adv
; 5(8): 2279-2283, 2021 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33904894
Resultados
1 -
4
de 4
1
Próxima >
>>